[XLS] Table 2 Adverse events and adverse drug reactions reported in the ...,https://synapse.koreamed.org/articles/Table.php%3Fxn%3Djrd-28-4-202%26jc%3D1010jrd%26id%3DT2%26mode%3Dexport
[XLS] jgo-33-e45-s004,https://ejgo.org/DownloadSupplMaterial.php%3Fid%3D10.3802/jgo.2022.33.e45%26fn%3Djgo-33-e45-s004.xls
[XLS] jgo-33-e45-s005,https://ejgo.org/DownloadSupplMaterial.php%3Fid%3D10.3802/jgo.2022.33.e45%26fn%3Djgo-33-e45-s005.xls
[XLS] Feuille1 Feuille1 A B C D E F G H I J K 1 Country Profession ...,https://www.ijidonline.com/cms/10.1016/j.ijid.2022.01.006/attachment/c95d3382-4735-40c3-bb79-a611429a7d34/mmc1.xls
[XLS] common stock A B C D E F G H 1 2 Common stock 3 4 5 Per share ...,https://investors.compasstherapeutics.com/static-files/2c8a2d58-54f6-471a-ad03-3bbaf24ce08c
[XLS] Table 3. Clinical manifestation of adverse events classified by ...,https://www.ekjm.org/journal/Table.php%3Fid%3Dt3-kjm-85-4-385-7%26mode%3Dexport
[XLS] Table 5. Number of adverse events that caused hospitalization or ...,https://www.ekjm.org/journal/Table.php%3Fid%3Dt5-kjm-85-4-385-7%26mode%3Dexport
[XLS] Table 2. Most common (reported by â‰¥ 10% of patients) treatment ...,https://www.e-crt.org/journal/Table.php%3Fxn%3Dcrt-2017-074.xml%26id%3Dt2-crt-2017-074%26mode%3Dexport%26number%3D2727
[XLS] Clinical and Experimental Pediatrics,https://www.e-cep.org/journal/Table.php%3Fxn%3Dkjped-59-456.xml%26id%3D%26mode%3Dexport
[XLS] Sheet1,https://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/Reverse_Mapping_CTCAE_4_to_CTCAE_3.xls
[XLS] Grades (CTC v2.0 to CTCAE v3.0),https://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/Mapping_CTC2_CTCAE3_MEDDRA10.xls
[XLS] Table 6. Mean overall severity of Consensus Auditory-Perceptual ...,https://www.e-asr.org/journal/Table.php%3Fxn%3Dasr-200086.xml%26id%3Dt6-asr-200086%26mode%3Dexport
[XLS] jla-8-221-s002 A B C D 1 Supplementary Table 2. Adverse events 2 ...,https://e-jla.org/DownloadSupplMaterial.php%3Fid%3D10.12997/jla.2019.8.2.221%26fn%3Djla-8-221-s002.xls
[XLS] aair-11-231-s002,https://e-aair.org/DownloadSupplMaterial.php%3Fid%3D10.4168/aair.2019.11.2.231%26fn%3Daair-11-231-s002.xls
[XLS] Table 4. Result of subjective evaluation (GRBAS) Subject G R B A S ...,https://www.e-csd.org/journal/Table.php%3Fxn%3Dcsd-24-3-814.xml%26id%3DT4-csd-24-3-814%26mode%3Dexport
[XLS] The Korean Journal of Internal Medicine,https://www.kjim.org/journal/Table.php%3Fxn%3Dkjim-2016-016.xml%26id%3Dt3-kjim-2016-016%26mode%3Dexport
[XLS] The Korean Journal of Pancreas and Biliary Tract,https://www.kjpbt.org/journal/Table.php%3Fxn%3Dkpba-23-3-108.xml%26id%3Dt4-kpba-23-3-108%26mode%3Dexport
[XLS] Table 4. Comparisons of GRBAS scale pre vs post voice therapy Pre ...,https://jkslp.org/journal/Table.php%3Fxn%3Djkslp-2019-30-1-48.xml%26id%3Dt4-jkslp-2019-30-1-48%26mode%3Dexport
[XLS] Table 1. Typical presentations of RRMS and atypical or red flag ...,https://www.jkna.org/journal/Table.php%3Fxn%3Djkna-36-4-273.xml%26id%3Dt1-jkna-36-4-273%26mode%3Dexport
[XLS] disclaimer,http://www.imi-protect.eu/documents/ReferencedatasetofADRs_WP3.1WP3.8.xls
